Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000567874 | SCV000673431 | likely benign | Hereditary cancer-predisposing syndrome | 2016-08-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000935514 | SCV001081263 | likely benign | Birt-Hogg-Dube syndrome | 2024-12-11 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV005248299 | SCV005897965 | benign | Birt-Hogg-Dube syndrome 1 | 2024-10-23 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |